AMYDERRO Trademark
AMYDERRO is a USPTO trademark filed by Prothena Biosciences Limited. Status: Registered.
Trademark Facts
| Mark | AMYDERRO |
|---|---|
| Serial Number | 87639430 |
| Registration Number | 6720927 |
| Status | Registered |
| Filing Date | 2017-10-10 |
| Registration Date | 2022-05-24 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Prothena Biosciences Limited |
| Attorney of Record | Jennifer L. Dean |
| Prosecution Events | 51 |
| Latest Event | NRCC on 2022-05-24 |
Goods & Services
Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes